DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 018841
NDA 018841 describes DAYPRO, which is a drug marketed by Gd Searle and is included in two NDAs. It is available from three suppliers. Additional details are available on the DAYPRO profile page.
The generic ingredient in DAYPRO is oxaprozin potassium. There are thirteen drug master file entries for this compound. Additional details are available on the oxaprozin potassium profile page.
The generic ingredient in DAYPRO is oxaprozin potassium. There are thirteen drug master file entries for this compound. Additional details are available on the oxaprozin potassium profile page.
Summary for 018841
| Tradename: | DAYPRO |
| Applicant: | Gd Searle |
| Ingredient: | oxaprozin |
| Patents: | 0 |
| Therapeutic Class: | Analgesics Anti-inflammatory Agents |
| Formulation / Manufacturing: | see details |
Pharmacology for NDA: 018841
| Ingredient-type | Nonsteroidal Anti-inflammatory Compounds |
| Mechanism of Action | Cyclooxygenase Inhibitors |
Suppliers and Packaging for NDA: 018841
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| DAYPRO | oxaprozin | TABLET;ORAL | 018841 | NDA | G.D. Searle LLC Division of Pfizer Inc | 0025-1381 | N | 0025-1381-51 |
| DAYPRO | oxaprozin | TABLET;ORAL | 018841 | NDA | G.D. Searle LLC Division of Pfizer Inc | 0025-1381 | N | 0025-1381-34 |
Profile for product number 004
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 600MG | ||||
| Approval Date: | Oct 29, 1992 | TE: | AB | RLD: | Yes | ||||
Complete Access Available with Subscription
